- Report: Pfizer seeks aid of PBMs in efforts to block generic versions of Lipitor
- New P&G initiative may create clash of the OTC titans
- Adherence among chronic disease patients can lead to big savings
- Perrigo 2012 targets: Prevacid 24HR and Align; Lipitor on the horizon?
- Three’s not a crowd: Top antacids hold their own
HYDERABAD — The Food and Drug Administration has approved two generic drugs made by Aurobindo Pharma, the drug maker said.
The company announced Tuesday the approval of quinapril tablets in the 5-mg, 10-mg, 20-mg and 40-mg strengths. The drug is a generic version of Pfizer's Accupril and is used to treat high blood pressure. Various versions of the drug had sales of about $49 million during the 12-month period ending in September, according to IMS Health.
Last week, the drug maker received approval for cefadroxil for oral suspension in the 250 mg-per-5 mL and 500 mg-per-5 mL strengths. The drug is a generic version of Warner Chilcott's Duricef and is a cephalosporin antibiotic for treating certain bacterial infections, including urinary tract infections caused by E. coli, P. mirabilis and Klebsiella bacteria; skin and skin-structure infections caused by staphylococci and streptococci; and pharyngitis and tonsillitis caused by Streptococcus progenies. Various versions of the drug had sales of about $6 million during the 12-month period that ended in September, according to IMS.